A peer-reviewed study on voice AI and depression screening shows why demographic portability testing matters before deploying clinical AI tools.
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Why Life Science Tech Pilots Fail After The Demo — And How To Avoid It
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
- How Versiti Turns Data Into A Lifeline For Rare Blood Patients
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Helping Biotechs Overcome 4 Key Challenges
Delays in site payments, participant reimbursements, and logistical inefficiencies can create roadblocks for patients and sites.
-
eClinical Platform Accelerates COVID-19 Treatment Trial By 2 Weeks
Examine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.
-
Tackling Feasibility In Rare Disease Clinical Trials
Rare disease clinical trials face distinct challenges, but the right data strategy can offer a transformative approach to addressing complexities and enhancing enrollment.
-
Benefits Of Using ePRO In Early Phase Studies
Discover how harnessing Patient Reported Outcomes electronically in early-phase trials can boost patient centricity, create more cost-effective operations, and help generate better data faster.
-
Transforming Field Rep Success
As the healthcare landscape evolves, maintaining accurate and timely information delivery becomes vital for building strong HCP relationships and improving patient outcomes.
-
Virtual eConsent For Decentralized Trials
Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.
-
The AI Revolution In Clinical Trials
AI is reshaping clinical trials by accelerating patient recruitment, optimizing protocol design, and improving data quality—driving faster, more efficient, and more inclusive research outcomes.
-
Overcoming 5 Challenges Of Implementing eClinical Technologies
Assess five common pitfalls trial teams face when incorporating new technology and identify potential solutions to mitigate the common risks.
-
Why More Sponsors Are Taking Control Of Clinical Trial Study Builds
Accelerate study startup and reduce rework by building studies directly in EDC. Discover a more flexible, efficient approach to managing clinical trials and data quality.
-
Real-Time Trials Need Real-Time Data You Can Trust
The FDA just kicked off real-time clinical trials with AstraZeneca and Amgen. But speed means nothing if the underlying data is inconsistent.
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
RECENT NEWSLETTERS
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech
- 07.23.26 -- AI, Data Costs, And The Real Barriers To Trial Execution
- 07.16.26 -- Why Clinical Trial Sites Are Drowning In Tech Chaos